QBDAX
Price
$8.50
Change
-$0.00 (-0.00%)
Updated
Sep 16 closing price
Net Assets
88.48M
VASIX
Price
$15.99
Change
-$0.00 (-0.00%)
Updated
Sep 16 closing price
Net Assets
3.96B
Interact to see
Advertisement

QBDAX vs VASIX

Header iconQBDAX vs VASIX Comparison
Open Charts QBDAX vs VASIXBanner chart's image
Quantified Managed Income Advisor
Price$8.50
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets88.48M
Vanguard LifeStrategy Income I
Price$15.99
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets3.96B
QBDAX vs VASIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QBDAX vs. VASIX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QBDAX is a Buy and VASIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VASIX has more cash in the bank: 3.96B vs. QBDAX (88.5M). VASIX pays higher dividends than QBDAX: VASIX (3.48) vs QBDAX (3.13). QBDAX was incepted earlier than VASIX: QBDAX (10 years) vs VASIX (31 years). QBDAX (2.26) is less costly to investors than VASIX (0.11). QBDAX is a more actively managed with annual turnover of: 718.00 vs. VASIX (5.00). VASIX has a lower initial minimum investment than QBDAX: VASIX (3000) vs QBDAX (10000). VASIX annual gain was more profitable for investors over the last year : 3.36 vs. QBDAX (2.18). VASIX return over 5 years is better than : 5.14 vs. QBDAX (0.05).
QBDAXVASIXQBDAX / VASIX
Total Expense Ratio2.260.112,055%
Annual Report Gross Expense Ratio2.260.112,055%
Fund Existence10 years31 years-
Gain YTD5.5907.90671%
Front LoadN/AN/A-
Min. Initial Investment100003000333%
Min. Initial Investment IRAN/AN/A-
Net Assets88.5M3.96B2%
Annual Yield % from dividends3.133.4890%
Returns for 1 year2.183.3665%
Returns for 3 years4.8318.6626%
Returns for 5 years0.055.141%
Returns for 10 yearsN/A33.64-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RCGHX15.13N/A
N/A
Virtus KAR Health Sciences C
NMAVX12.34N/A
N/A
Nuance Mid Cap Value Investor
MDODX11.85N/A
N/A
Morgan Stanley Developing Opportunity R6
RAPAX11.15N/A
N/A
Cohen & Steers Real Assets A
JANIX27.71-0.03
-0.11%
Janus Henderson Triton D